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Recent efforts in our laboratory have concentrated on autoimmune mecha-
nisms producing an experimental interstitial nephritis called anti-tubular base-
ment membrane (anti-TBM)' disease (1) . Anti-TBM disease is induced in rodents
after an immunization with renal tubular antigen (RTA) in adjuvant . Susceptible
animals expressing the endogenous antigen (2) develop antibodies to the tubular
basement membrane (anti-TBM-Ab) (3), a complex nephritogenic T cell reper-
toire (4), active fibrogenesis (5), interstitial cell infiltrates, and progressive renal
failure . Such renal lesions can also spontaneously develop in patients, resulting
in progressive renal insufficiency (6-8) . Both the nephritogenic antigen (3M-1)
in the experimental model and the target antigen of human disease are cross-
reactive moieties of similar size (48,000 Mr) (9) . This association is seemingly
unique among immune-mediated renal lesions, and supports the notion that
experimental anti-TBM disease may be analogous to the human condition .
With the ability to now isolate the active nephritogenic moiety of anti-TBM
disease, we have extended our previous observations to provide a detailed anal-
ysis of its paratypic recognition by the autoimmune B cell repertoire . A library
of 22 rat anti-TBM mAbs, each specific for the nephritogenic antigen (3M-1),
was constructed for this analysis from five separate fusions . Their characteriza-
tion revealed an anti-TBM (anti-3M-1) B cell population that consists of -58
distinct clones that express at least three VH gene families, widely variable affin-
ities, a broadly crossreactive idiotype (IdX), but single specificity for an immu-
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￿
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raphy ; IdX, crossreactive idiotype ; RTA, rabbit renal tubular antigen ; SRTA, collagenase-solubilized
renal tubular antigen .
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1296-1312nodominant epitope. A representative rat anti-TBM mAb, furthermore, was
capable of inhibiting >80% of the binding of polyclonal human anti-TBM anti-
sera. Finally, we demonstrate that polyclonal anti-IdX-Ab can be used therapeu-
tically, not only to prevent the induction of experimental disease, but also to
arrest the progression of the renal lesion.
Animals
Brown Norway (BN) and Lewis rats were purchased from Charles River Breeding Lab-
oratories, Inc., Wilmington, MA.
Antigens
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Materials and Methods
Rabbit RTA was prepared by differential sieving (10). Collagenase digestion of RTA
to produce collagenase-solubilized renal tubular antigen (SRTA) was accomplished with
bacterial collagenase (CLS IV; CooperBiomedical, Inc., Malvern, PA) in the presence of
protease inhibitors (11). Rabbit and human 3M-1 were isolated from SRTA using affinity
chromotography (2, 9).
Monoclonal Antibodies
Draining lymph node cells were harvested on day 18 from Brown Norway rats immu-
nized on days 0 and 14 with RTA in CFA, and were fused to Sp2 cells using standard
hybridoma technology (12) . Acidic supernatants of wells with growing hybridomas were
screened by indirect immunofluorescence on Brown Norway rat kidney sections with flu-
orescein-conjugated anti-rat IgG, and those that displayed linear staining of the TBM
without glomerular staining were considered preliminary positives. These presumptive
positives were then examined on kidney sections from Lewis rats, a strain generally
acknowledged to lack the target antigen of anti-TBM disease (3, 13, 14). If negative on
these sections, they were doubly subcloned at 0.5 cells/well.
Characterization of mAbs
Subclass: Light Chain. This was determined by Ouchterlony immunodiffusion of
serum-free (HB101 ; NEN Research Products, Boston, MA) hybridoma supernatants with
rat IgG subclass or K light chain antisera (Gateway Immuno-Sera Company, St. Louis,
MO).
Quantitation ofAnti-TBMmAb.
￿
Because all anti-TBM mAb were of the IgG1 or IgG2a
subclass, two reference hybridomas representing each subclass were used to make ascites
in pristane-primed nude mice. The respective mAbs were then purified by fast-perfor-
mance liquid chromatography (FPLC, Pharmacia Fine Chemicals, Inc., Piscataway, NJ)
and quantitated for use in constructing a standard curve. Solid-phase RIAs were per-
formed by serially diluting the reference and test anti-TBM mAbs into the wells of poly-
vinyl chloride (PVC) microtiter plates (Dynatech Laboratories, Inc., Alexandra, VA) in
HB101 medium. The wells were blocked with 4% BSA and developed with affinity-puri-
fied ...I-goat anti-rat IgG (Zymed Laboratories, San Francisco, CA). Unknown anti-TBM
mAb concentrations were determined by extrapolation to the appropriate (either IgGI
or IgG2a) standard curve.
Specificity and Relative Affinity.
￿
Recognition of 3M-1 was also evaluated by a solid-
phase RIA in which serial dilutions of HB101 hybridoma supernatants were incubated
in PVC wells lined with constant amounts (250 ng/well) of rabbit 3M-1 . The reaction was
developed with affinity-purified ' 21I-goat anti-rat IgG. Relative affinity was determined
by comparing quantities of mAb required to achieve 50% of maximum binding to 3M-1 .
Two monoclonals (56R-7 and 57R-2) had been previously assigned binding affinity con-
stants (Shih, W. Y., M. D. Clayman, C. J. Kelly, W. Hines, and E. G. Neilson, submitted
for publication) after formal Scatchard plot analysis using the method of Frankel and
Gerhard (15).
Isoelectric Focusing Patterns. Anti-TBM mAbs of the same subclass and light chain,1298
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which had relative affinities within 25% of each other, were assigned to one of five arbi-
trary groups for isoelectric focusing to determine possible identities . These candidate
anti-TBM mAbs were FPLC purified and then run in a vertical 5.5% polyacrylamide gel
using LKB ampholytes to achieve a pH range of 3.5-10 (16) . Focused gels were then
labeled with affinity-purified 1251-mouse anti-rat IgG and developed by autoradiography
(17) .
Quantitative Estimation of the Anti-TBM B Cell Repertoire.
￿
The identical pair formula,
as adapted by Briles and Carroll (18), was used to provide a quantitative estimate of the
anti-TBM B cell repertoire . This formula states : R = [n(n - 1)/2]/ [E a;(a; - 1)/2],
-i
where R is the number of distinct TBM-specific B cells ; n is the total number of relevant
monoclonal anti-TBM antibodies (anti-TBM mAb) ; a ; is the number of anti-TBM mAbs
with identity i ; i is a particular anti-TBM mAb that shares identity wtih one or more other
anti-TBM nAbs; and m is the total number of such identical groups .
Paratypic Analysis.
￿
The epitopic specificity of each anti-TBM n Ab was assessed by
competitive inhibition RIA. Increasing concentrations of different unlabeled anti-TBM
mAbs were admixed with constant amounts of a labeled anti-TBM nAbs (' 251-57R-2;
radiolabeled by the chloramine T method [19]) and the mixture was added to PVC
microtiter plates that had been previously lined with 3M-1 (250 ng/well) . After 2 h of
incubation, plates were washed and wells were counted in a gamma counter.
VHAnalysis.
￿
Hybridomas were grown to 108 cells, washed twice with sterile PBS, and
their RNA was extracted by lithium chloride precipitation (20) or homogenization in
guanidinium thiocyanate (21). RNA was then separated on 1% agarose in 2.2-M formal-
dehyde gels, transferred to nylon filters, and analyzed with three different murine VH
probes . These were pVHS107 from the 5107 family (22), pVHQ52N from the Q52 fam-
'1 (22), and pVhSAPC-15 from the 7183 family (22) . Probes were nick translated with
[Z2P]dCTP and were added to hybridization buffer at a concentration of 106 cpm/m l .
After low- and high-stringency washes, filters were exposed to XAR-5 film (Eastman
Kodak Co .) in cassettes containing Cronex Lightning-plus intensifying screens (DuPont
Co ., Wilmington, DE) at -70°C for 3-5 d and were then developed .
Preparation of Anti-IdX-Ab
10 anti-TBM mAbs were initially used as immunogens to potentially induce an anti-
IdX antisera . Only one (53R-4) was found to be inductive (see Results) . This antisera was
prepared in the following way: anti-TBM mAb 53R-4 was FPLC purified from ascites,
mixed with CFA, and used to immunize an outbred rabbit subcutaneously at 0 (200 tUg
53R-4), 2 (100 ug), and 4 wk (100 wg) . At 5 wk, harvested serum was exhaustively
adsorbed over a normal BN serum (50%-saturated ammonium sulfate precipitate)
Sepharose 4B (Pharmacia Fine Chemicals) affinity column to remove reactivity with Ig
constant region or framework determinants . Adsorbed anti-53R-4 antisera was titered
against 53R-4 in a solid-phase RIA. Reactivity with BN IgG and normal rabbit serum
reactivity with 53R-4 were also determined as specificity controls . A competitive inhibi-
tion RIA was then performed in PVC microtiter plates lined with 250 ng/well of 53R-4 .
25-,ul aliquots consisting of equal volumes of increasing concentrations of various FPLC-
purified anti-TBM mAbs and a 1 :1,500 dilution of rabbit anti-53R-4 antisera (which rep-
resented twice the 50% maximum binding value) were then applied to the PVC plate and
developed with '251-anti-rabbit IgG.
Treatment ofAnti-TBM Disease with Anti-IdX Antisera
0.5 ml of anti-IdX antisera (anti-53R-4) was administered intravenously to four BN
rats 2 d before and on the day of immunization with 2 mg of RTA/CFA . Another group
of four BN rats also received 0 .5 ml of IdX antisera on days 14 and 16 after immuni-
zation . Control groups consisted of animals immunized with RTA/CFA or CFA alone
without any antisera administration, and RTA/CFA-immunized animals that received
normal rabbit serum instead of anti-IdX antisera . Two animals from the RTA/CFA con-
trol group were also killed at 14 d, and their kidneys were examined to establish baselinehistology. All of the other animals in all groups were killed on day 27. Kidneys were
preserved in 10% buffered formalin, set in paraffin blocks, sectioned, and stained with
hematoxylin and eosin. Sections were read without knowledge of experimental groups.
The intensity of the cortical interstitial mononuclear cell infiltrate was graded on a pre-
viously published (23) scale of 0 to 4+ : 0, no infiltrate; 1+, <25% of cortex involved;
2+, 25-50% of cortex involved; 3+, 50-75% of cortex involved; 4+, >75% cortex
involved. Delayed-type hypersensitivity (DTH) reactions to SRTA and purified protein
derivative were measured on the day of sacrifice, 24 h after footpad challenge with 25 A
g of SRTA or PPD in 25 Al of PBS. Swelling was determined by a spring-loaded engi-
neer's micrometer (Schlesingers for Tools Ltd., Brooklyn, NY) and was read as incre-
mental swelling (in 10-s in) compared with PBS-injected controls (4). Serologic anti-
TBM-Ab (anti-3M-1) responses were quantitated by solid-phase RIA (20) .
Specificity of anti-TBM-Abfrom Human Antisera
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PVC plates were lined with human 3M-1 (250 ng/well) and reacted with serial dilutions
of human anti-TBM-Ab (9). Reactions were developed with affinity-purified 1251-anti-
human IgG. The serial dilution representing 50% of maximum binding was then used to
examine the ability of increasing concentrations of a rat anti-TBM mAb (56R-9) to com-
petitively inhibit the binding of human anti-TBM-Ab to 3M-1 . In this assay, aliquots of
the human antiserum dilution representing twice the 50% maximum binding value were
admixed with equal volumes of increasing concentrations of the rat anti-TBM mAb for
30 min and then were applied to PVC plates previously lined with human 3M-1 . Reac-
tions were developed with 1251-anti-human IgG and counted in a gamma counter.
Results
Library of Rat Anti-TBM mAb.
￿
22 IgG anti-TBM mAb were isolated from five
different fusions. As shown in Table I, 20 of the 22 IgG possessed K light chains
and all were either of the IgGI or IgG2a subclass . By indirect immunofluores-
cence, these all demonstrated linear TBM staining on BN rat kidney sections,
but were negative on Lewis rat kidney (data not shown). Each was reactive with
3M-1 in a solid-phase RIA. There was an exact correlation between immunoflu-
orescent positivity and 3M-1 reactivity. The relative binding affinities, expressed
as the quantity of mAb required to achieve 50% of maximum binding to 3M-1
in a solid-phase RIA, spanned a broad range (Table I). To place these data in
perspective, formally determined binding affinity constants for 56R-7 and 57R-
2 are 6 X 106 liters/mol and 2 X 108 liters/mol, respectively (Shih, W. Y., M .
D. Clayman, C. J. Kelly, W. Hines, and E. G. Neilson, submitted for publication).
Fig. 1 shows the binding curves of several representative anti-TBM mAbs to
3M-1 .
Epitopic Specificity.
￿
The ability of unlabeled anti-TBM mAb to competitively
inhibit binding of 1251-57R-2 to 3M-1 was assessed by solid-phase RIA (Fig. 2).
In this representative figure, all anti-TBM mAb, over the dosage range exam-
ined, inhibited >50% of 1251-57R-2 binding, whereas BN rat IgG did not sub-
stantially inhibit at all. In fact, all 22 anti-TBM mAbs were tested and all but
one of these displayed comparable competitive inhibition curves. Anti-TBM
mAbs 56R-1 inhibited somewhat less, to a maximum of 40% (data not shown) .
These data collectively suggest that nearly all of the anti-TBM mAbs from five
separate fusions may be directed to an immunodominant epitope on 3M-1 .
Quantitation of the anti-TBM B Cell Repertoire.
￿
The identical pair formula (17)
predicts that the number of distinct members of a specific clonotype is inversely1300
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TABLE I
Library ofAnti-TBM mAbs
immunodiffusion .
: Supernatant concentration was determined in a solid-phase RIA .
4 Quantity ofmAb (in ng) necessary to achieve 50% of maximum binding
to 3M-1 in a solid-phase RIA .
Lack of recognition by anti-K antisera .
proportional to the likelihood of finding identical anti-TBM mAbs from differ-
ent hybridomas . This was used to estimate the size of the anti-TBM B cell rep-
ertoire. For anti-TBM mAb that expressed the same light chain and subclass and
had similar binding curves to 3M-1, isoelectric focusing was performed as a
means of determining identity. 13 anti-TBM mAb were placed in five arbitrary
groups of apparent similarity and their isoelectric points were determined by
electrophoresis . Three of four anti-TBM mAb in group 1 and 2 of three anti-
bodies in group 2 appeared to have identity . Fig . 3 illustrates the focusing pat-
terns for groups 2 and 5 . Thus, the identical pair formula estimates the size of
the anti-TBM B cell repertoire at -58 distinct clones, of which 19 were repre-
sented in this report .
Analysis of Hybridoma VH Genes .
￿
Evaluation by Northern hybridization of six
hybridomas with probes to three murine VH gene families known to crosshy
bridize strongly with different rat VH genes indicated (Table II) that RNA from
two hybridomas hybridized with the Q52 family (an IgM-sized band also hybrid-
Anti-TBM mAb
Phenotypes*
Light chain Isotype
Supernatant :
concentration
Relative
3M-1 binding
affinity
kg/ml
5311-1 K IgG2a 28.2 2.75
5311-2 K IgGI 2.7 >68.00
5311-3 -1 IgG1 6.0 >150.00
5311-4 K IgG2a 15.6 2.75
5311-5 K IgG2a 18.6 2.50
5511-1 K IgG2a 20.0 0.74
5611-1 K IgGI 31 .0 19.00
5611-2 K IgG2a 30.4 2.85
5611-3 K IgG2a 25.2 4.00
5611-6 K IgG2a 78.0 1 .70
5611-7 K IgG1 17 .2 400.00
5611-9 K IgGI 4.8 0.22
5611-11 K IgG2a 304.0 >400.00
5611-12 K IgG2a 22.8 30.00
5711-1 K IgG2a 33 .0 0.73
5711-2 K IgG1 8.0 0.33
5711-3 K IgG1 25 .8 0.50
5711-4 -u IgGI 11 .2 <0.07
5711-6 K IgG2a 33 .6 0.95
5711-7 K IgG2a 75 .6 3.40
5711-8 K IgGI 34.8 <0.21
C1-12 K IgG1 7.2 0.73
* Light chain and isotype were determined by Ouchterlony1001
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FIGURE 1 .
￿
Solid-phase RIA of representative anti-
TBM InAbs binding to 3M-1 . HB101 supernatants,
containing known amounts of anti-TBM mAb, were
serially diluted and added to PVC microtiter plates
lined with 250 of/well of 3M-1 . The reaction was
developed with 12 I-anti-rat IgG. (--1 M ￿-) anti-TBM
0 1 O I
￿
1
￿
.
￿
. F mAb 56R-6; (-A-) anti-TBM mAb 56R-9; (-*-)
AP00160 10
￿
1 0 .1 0.01
￿
anti-TBM mAb 56R-3; (-D-) anti-TBM mAb 56R-
7; (O) mediacontrol, Maximum cpm in this assay was
MONOCLONAL ANTI-TBM ANTIBODY (ng)
￿
4,666.
25
ized in hybridoma 56R-3) ; RNA from two hybridomas hybridized with the 7183
family (with borderline recognition of a third); and RNA from two other hybri-
domas did not hybridize with any ofthese VH probes. A representative Northern
blot is shown in Fig. 4. The IgM-sized RNA band from 56R-3 is presumed to
be from a nonproductive Igh rearrangement because all anti-TBM mAb in this
study have been shown to be of the IgG class (Table I). FPLC analysis of super-
natants from 56R-3 did not reveal any IgM-sized protein (data not shown), indi-
cating that the protein product of this larger mRNA is not cosecreted with the
FIGURE 2. Competitive inhibition of 1251-57R-2
binding to 3M-1 by representative "cold" anti-TBM
mAb. Serial dilutions of inhibitors (anti-TBMmAb or
BN rat IgG) were admixed with equal volumes of 1251-57R-2, and aliquots were added to 3M-1-lined
PVC microtiter wells. 1251-57R-2 reactivity with an
irrelevant antigen (BSA) was <1% of maximum. (A)
Uninhibited '251-57R-2. Inhibitors: (--0-) normal
BN IgG; (--W---) 57R-2; (-0-) 56R-6; (-v-)
53R-4; (-A-) 56R-7; (-D-) 56R-9. Maximum
QUANTITY OF INHIBITOR ADDED (ng)
￿
cpm in this assay was 25,599.
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IgG. These data collectively suggest, therefore, the existence of at least three
different VH region gene families for the hybridomas examined . While two
hybridomas of widely differing affinities (56R-7 and 57R-2) used VH gene seg-
ments from the same family (Q52), three hybridomas (56R-3, 56R-7, and 57R-
2) that shared a crossreactive idiotype (see below) were derived from two differ-
entVH families (Q52 and 7183) .
Shared Paratypic Specificity . Previous work (9) had demonstrated that the
nephritogenic antigen of experimental anti-TBM disease was crossreactive with
the target antigen of human anti-TBM disease . Given the finding of a presumed
immunodominant epitope on rabbit 3M-1, we tested the possibility that a similar
crossreactive epitope might exist on human 3M-1, and also that the serological
anti-human 3M-1 response might also focus to this determinant. Consequently,
FIGURE 3 .
￿
Isoelectric focusing patterns from two groups
(G2 and G5) of anti-TBM mAbconsidered to have potential
identity. G2 : 55R-1 and 57R-6 appear to be identical, but
are different from 57R-1 . G5 : 57R-3 and C1-12 do not
appear to be similar .
S107
* HybridomaRNAwas blotted and analyzed with labeled DNAprobes spe-
cific for the indicated gene families .
Hybridoma*
Analysis
IdX
TABLE II
of IgG Hybridoma
Q52
V Genes
V gene family
7183
57R-1 - - -
57R-2 + + -
53R-3 ND - +
56R-7 + + ±
56R-3 + +(Igm) +
57R-6 ND - -we assessed the ability of 56R-9 to competitively inhibit the binding of human
anti-TBM antisera (from a patient with spontaneous anti-TBM disease and renal
failure) (9) to human 3M-1 . As shown in Fig . 5, 56R-9 is capable of inhibiting
>80% of human anti-TBM antisera reactivity with human 3M-1 . Purified BN
IgG does not inhibit at all .
Idiotypic Analysis.
￿
10 anti-TBM mAbs were FPLC purified from ascites and
were used to riase rabbit antiidiotypic antisera. Nine of these antisera only rec-
ognized private idiotypes on their respective immunogen . One of them, how-
ever, rabbit anti-53R-4 idiotype, could be competitively inhibited by five of
too
75
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FIGURE 5 . Epitopic focusing of polyclonal human
anti-TBM antisera. Serial dilution of inhibitors (56R-
9 [--4-] or BN rat IgG [-O-]) were admixed
with human anti-TBM antisera (1:1,000 final dilu-
tion) andadded to human 3M-1-lined PVCmicrotiter
wells in a solid-phase RIA . The reaction was devel-
oped with 1251-anti-human IgG . (--~-) Uninhib-
ited humananti-TBM antisera. The specificity of this
0 (
￿
~
i
t
￿
l0
￿
100 tpoO 10l000
￿
antisera for the target antigen of human anti-TBM
disease (human 3M-1) has been previously estab
QUANTITY OF INHIBITOR ADDED (ng)
￿
lished (9) . Maximum cpm in this assay was 7,588 .
25
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FIGURE 4 . Representative Northern blot of hybridoma RNA .
DNA probe pVhQ52N (from the Q52 family) was nick translated
and hybridized to Northern blotted hybridoma RNA as shown .
There is recognition of IgG-sized RNA from both 56R-7 and 57R-
2 . Higher molecular weight RNA (presumed IgM) from 56R-3 is
also recognized.1304
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FIGURE 6 .
￿
(A) Specificity of anti-(53R-4 idiotype) antiserum. Appropriately adsorbed rabbit
anti-(53R-4 idiotype) antiserum or normal rabbit serum was serially diluted and reacted with
53R-4 or BN rat IgG-lined wells (250 ng/well) in a solid-phase RIA . The reaction was devel-
oped with 1251-anti-rabbit IgG . (-A~-) Rabbit anti-(53R-4 idiotype) antiserum vs . 53R-4;
(-4F--) rabbit anti-(53R-4 idiotype) antiserum vs . BN rat IgG; (-O-) normal rabbit serum
vs . 53R-4 . Maximumcpm in this assaywas 35,833 . (B) Rabbit anti-(53R-4 idiotype) antiserum
recognition of a cross-reactive idiotype . In a competitive inhibition RIA, wells were lined with
53R-4 (250 ng/well) and were reacted with an admixture of serially diluted inhibitor and
rabbit anti-(53R-4 idiotype) antiserum (1 :3,000 final dilution) . The reaction was developed
with 1251-anti-rabbit IgG . Inhibitors : (-4&-) BN IgG : (--*-) 53R-4; (-O-) 56R-3 ; (-
0-) 57R-1 ; (-EJ-) 56R-7; (-v-) 57R-2 ; (-A-) 56R-9 ; (-A-) 53R-1 ; (-V-)
uninhibited rabbit anti-(53R-4 idiotype) antiserum recognition ofBN IgG. Maximum cpm in
this assay was 13,811 .
seven randomly selected anti-TBM mAb (Fig . 6), whereas BN IgG did not inhibit
at all . These data suggest that 53R-4 expresses an IdX shared by other anti-
TBM-Ab in the B cell repertoire .
Treatment of anti-TBM Disease with anti-IdX Antisera .
￿
The ability of an anti-
IdX-Ab (rabbit anti-53R-4) to inhibit the pathogenesis of experimental anti-TBM
disease was examined at two time points . As shown in Table III, BN rats (group
3) that received anti-IdX-Ab in the perhmmunization period (2 d before and on
the day of immunization) had essentially no interstitial infiltrates when killed 4
wk later (group 3 average pathology score was 0 .3) . In contrast, animals that
received either no treatment or normal rabbit serum developed severe intersti-
tial nephritis with average pathologic scores of 3 .9 (group 1) and 3.5 (group 2),
respectively . The average pathology scores of untreated animals (group lb) was
1 .8 at 2 wk compared with 3 .9 in group 1 rats at 4 wk. Animals that received
0.5 ml of anti-IdX-Ab on days 14 and 17 (group 5) had average pathologic
scores of 1 .6 at 4 wk, whereas animals treated with normal rabbit serum (group
4) progressed to an average pathologic score of 3.8 . Thus, anti-IdX-Ab was bothw
a
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FIGURE 8. Serological anti-TBM-Ab response in
animals from anti-IdX experiment. In a solid-phase
RIA, wells were lined with 3M-1 (250 ng/well) and
were reacted with serial dilutions of pooled sera from
each treatment group. The reaction was developed
with 1211-anti-rat IgG. All RTA/CFA-immunized
groups made substantial titers of anti-3M-1 antibod-
ies. (-"-) group 1; (-40-) group II; (-0-)
group III; (-O-) group IV; (-O-) groupV; (-
A-) group VI. Maximum cpm in this assay was
16,856.
effective in preventing the development of interstitial injury and in halting its
progression. Representative interstitial lesions are shown in Fig. 7. DTH reac-
tions to SRTA were similar among all groups except groups 3 and 6, which had
greatly reduced responses (Table III). Periimmunization treatment of group 3
with anti-IdX-Ab, therefore, resulted in the abrogation of T cell responses pro-
ducing both DTH (24) and the development of interstitial lesions. Group 5 rats
treated with anti-IdX-Ab 2 wk after immunization with RTA/CFA experienced
an arrest in the progression of disease, but no loss of DTH reactivity, which is
consistent with presence of residual interstitial infiltrates and some antigen-reac-
tive T cells. Animals in all groups made excellent and indistinguishable DTH
responses to PPD, and all groups immunized with RTA/CFA produced compa-
rable anti-TBM-Ab (anti-3M-1) responses (Fig. 8).
Discussion
A detailed analysis of autoreactive responses may not only reveal critical fea-
tures of immunopathogenesis, but also may suggest potential therapeutic strat-
egies for interrupting destructive autoimmune events. In the current study, 22
anti-TBM mAbs from five different fusions were isolated and characterized for
just such an analysis. Because antibodies with specificity for the TBM do not
arise spontaneously in BN rats, lymphoid cells were obtained from animals
immunized with a xenogeneic tubular antigen, which is the standard method for
inducing experimental anti-TBM disease. All monoclonals identified as prelimi-
nary positives by immunofluorescent criteria (i.e., staining of BN rat TBM, but
not Lewis rat TBM; the latter strain lacks the target antigen of anti-TBM disease)
were uniformly reactive with the nephritogenic antigen of anti-TBM disease,
3M-1 . This suggests that the autoreactive B cell response in BN rats is quite
restricted in its specificity to that family of basement membrane constituents
bearing 3M-1 epitopes. This is consistent with the finding that polyclonal anti-
sera from animals injected to produce disease stain only TBM-related structures
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Quantitative assessment of the TBM-reactive B cell repertoire, based on our
fusion experience, indicates the presence of ^-58 distinct clones . This estimate
is based on the identical pair formula as modified by Briles and Carroll (18), and
depends on the finding that some of the 22 anti-TBM mAbs were identical by
criteria of subclass, light chain, relative affinity, and isoelectric focusing pattern .
Because our fusions used lymphoid cells of antigen-primed and -boosted ani-
mals, it is possible that the naive TBM-reactive premature B cell population is
somewhat larger than the above estimate. This is because the selective pressure
of immunization may tend to favor expansion of those B cells bearing surface
Ig of somewhat higher affinity. A similar approach has been used to quantify
the anti-DNA B cell repertoire in the autoimmune (NZB X NZW)F, mouse at
80 distinct clonotypes (25) . Other estimates in mice provide figures that range
from 100 to 300 for antistreptococcal group A carbohydrate (anti-GAC) anti-
bodies (26) to several thousand for anti-4-hydroxy-5-iodo-3-nitrophenyl acetyl
(anti-NIP) antibodies (27) .
The molecular basis of the anti-TBM B cell repertoire was analyzed using
probes that define distinctive murine VH region gene families and crosshybridize
with rat VH genes families (22, 28). Comparable data in the rat, to our knowl-
edge, does not exist for other autoimmune B cell repertoires . Dominant VH
gene family representation amongst murine autoantibodies, however, has been
reported in several studies (29-32). These mouse autoantibodies, while varying
in their specificities, nevertheless, can sometimes display preferential use of the
3' families, Q52 and 7183, although this is not always the case (33) . They also
frequently possess crossreactive idiotypes not always restricted to single a VH
gene family (31, 34) . This work in the mouse is surprisingly consistent with our
data regarding both VH gene family use by anti-TBM mAbs and the expression
of IdX. Four of six of our antibodies were derived from Q52- and 7183-like
genes (Table II). These data represent the first suggestion that biased usage of
VH gene families for autoantibody generation in the mouse might similarily
apply to the rat . Three of our IdX-bearing anti-TBM mAbs (56R-3, 56R-7, and
57R-2), which were examined for heavy chain gene origin, crosshybridized with
either Q52 or 7183 probes (Table II ; Fig . 4) . IdX- mAb (57R-1), which was also
subjected to VH gene analysis, was derived from neither Q52 nor 7183 families .
Our findings are consistent with a biased VH gene usage among rat autoanti-
bodies, that a crossreactive idiotype is readily demonstrable, and that such an
IdX can be specified by more than one VH gene family . Although some IdX
antibodies can also be specified by VL genes (35), we have observed, in prelim-
inary experiments, that our anti-IdX-Ab only binds to heavy chains on Western
blots (data not shown) . Additionally notable is the finding that both 56R-7 and
57R-2 share the same VH gene family (Q52) but have substantially different
affinity constants (6 X 10 fi/mol and 2 X 108/mol, respectively) . This may reflect
contributions to binding affinity made by either relatively small differences in
VH chain amino acid sequence, light chain differences, or D or J chain
differences .
On the surface it would also seem from our quantitative estimate of B cell
clonotypes and the eclectic use of Vt-H gene families that the B cell repertoire
producing anti-TBM-Ab would be at least moderately diverse . Closer analysis,CLAYMAN ET AL.
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however, reveals striking similarities among these otherwise distinctive monoclo-
nals. Virtually all the anti-TBM-Ab competitively inhibit the recognition of
3M-1 by a radiolabeled reference anti-TBM mAb, suggesting the common rec-
ognition of the same or nearly identical epitope. This point is qualified by the
consideration that some inhibition could be secondary to stearic hindrance or
conformational changes in 3M-1 after anti-TBM-Ab binding to an unrelated epi-
tope, and must await further peptide analysis. A single anti-TBM mAb (56R-9)
is also capable of inhibiting >80% of the binding of polyclonal human anti-
TBM-Ab antisera to its ligand, human 3M-1 (Fig. 6). Taken together, these find-
ings support the concept that while the humoral immune response in rats and
humans with anti-TBM disease is formed by a moderately diverse population of
B cells, the paratypic specificity of this response is focused to an immunodomi-
nant epitope, and conserved among some mammals.
This conserved paratypic specificity in rats is also reflected in the demonstra-
tion of broadly crossreactive idiotype. Crossreactive idiotypes have previously
been described in experimental thyroiditis (36, 37) and in lupus mice (25).
Although the induction of andidiotypic immunity with anti-IdX-Ab was partially
effective in attenuating progressive renal injury in lupus mice (38), our anti-IdX
antisera, when administered to BN rats at the time they were immunized to pro-
duce anti-TBM disease, was capable of specifically preventing renal injury. These
animals also had attenuated T cell responses (as measured by DTH to SRTA),
but only very slightly lower serum anti-TBM-Ab titers. The ability of anti-IdX
antisera to influence T cell responses may reflect the previously documented
serologic sharingof idiotypic determinants between anti-TBM-Ab and 3M-1-spe-
cific T cells (4). That such treatment did not markedly influence the amplitude
of the anti-3M-1 antibody response is consistent with results of xenogeneic anti-
idiotypic manipulation in other systems (39, 40). Further, the finding that
humoral immune responses to 3M-1 were similar among all RTA/CFA immu-
nized groups (Fig. 8), implies that anti-TBM-Ab, per se, in a uniformly suscep-
tible strain, are not sufficient for the induction of disease (3). Also of note was
the demonstration that anti-IdX antisera was effective in arresting the progres-
sion of disease when given 2 wk after immunization at a time when moderately
severe interstitial nephritis was already present. While previous studies from this
laboratory (24, 41) and others (42) have documented the effectiveness of anti-
idiotypic manipulation in anti-TBM disease, this is the first demonstration of the
therapeutic usefulness of an anti-IdX-Ab even after effector T cell mechanisms
had inflicted a moderate degree of renal damage. The available data do not pro-
vide a definitive statement regarding the lastingeffect of this intervention. Thus,
it is conceivable that kidneys of group 5 animals would have either progressed
to severe interstitial damage or returned to normal over a time frame more pro-
longed than that used in this experiment. The resolution of this issue will
require further study.
Summary
Experimental anti-tubular basement membrane (anti-TBM) disease is an
autoimmune interstitial nephritis elicited in susceptible rodents after immuni-
zation with renal tubular antigen. The nephritogenic antigen in the immunizing131 0
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preparation is 3M-1, a 48,000 M, noncollagenous glycoprotein . The hallmarks
of the renal lesion are the presence of anti-TBM antibodies (anti-TBM-Ab) and
a dense mononuclear cell infiltrate . The anti-TBM B cell repertoire in this dis-
ease was analyzed using a library of 22 anti-TBM mAbs generated in a prototyp-
ically susceptible Brown Norway rat . These anti-TBM mAbs were all demon-
strated to be 3M-1 specific and their characterization formed the basis for the
following observations : (a) The size of the anti-TBM B cell population is esti-
mated at 58 distinct clones ; (b) by competitive inhibition criteria, all anti-TBM
mAbs recognize the same (or spatially close) epitope(s) on 3M-1 . This focused
recognition was maintained in spite of considerable variability in affinity . Epi-
topic dominance could also be demonstrated in human polyclonal anti-TBM
antisera from a patient with anti-TBM disease ; and (c) a crossreactive idiotype
was documented, and antisera directed toward this set of variable region deter-
minants was shown to be effective as a prophylactic regimen to abrogate disease,
and as a therapeutic modality to arrest the progression of disease ; (d) analysis of
VH gene families suggested biased usage of Q52- and 7183-like families,
although at least three gene families are used in the anti-TBM-Ab response .
Thus, the anti-TBM B cell compartment in BN rats is moderately large, but is
primarily focused to a single epitope on the nephritogenic antigen and is asso-
ciated with a disease-modifying crossreactive idiotype .
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